L10: Potential antihypertensive targets in vascular smooth muscle Flashcards
What is BP?
What is cardiac output?
Blood pressure = Cardiac Output x systemic resistance
ardiac output = Stroke volume x heart rate
Examples of Adrenorecpeotr agonists and their effects on vasculature
Isoprenaline = beta adrenoreceptor (stimulate cardiomyocytes & pacemaker cells + relaxes arteries) agonist – no/little change in mean BP, HR increases
NA acts preferentially on the alpha adrenoceptors – causes constriction of blood vessels, HR increases slightly then decreases, BP goes up (due to increase in systematic resistance)
Why bother treating high bp?
Overview of the RAAS
-Antihypertensives usually target angiotensin II activity – ACE is targeted or by blocking the receptors angiotensin II works on
-This affects peripheral resistance, sympathetic nervous discharge, aldosterone release
Examples of renin antagonists
Aliskiren (a.k.a Tekturna) – renin antagonist:
- >causes reduction in the negative feedback induced by ACEis or ARBs
-> this rises Renin
-> Renin has other effects upon stimulating the RAAS:
1. Ang 1-7 – have biological effects + can interconvert
2. Chymase can create Ang II
RAAS in the brain
APA + APN important
Angiotensin I & II receptor affinity
- exhibit similar affinity for AT1 and AT2 receptors.
-They also have a similar affinity for a non-AT1, non-AT2 angiotensin-binding site
How does the brain RAS (renin-angiotensin system) control BP?
- Increase in vasopressin release from the posterior pituitary into the bloodstream
- activation of sympathetic premotor neuron activity at the level of the rostral ventrolateral medulla (RVLM) in the brain stem
- inhibition of the baroreflex at the level of the nucleus of the solitary tract (NTS) – leads to vagal stimulation
Example of an inhibitor of APA + APN
EC33 high affinity for APA, lower affinity for APN
Effect of EC33 in the brain
EC33 has a high affinity for APA and blocks it
- Central administration of EC33 blocked the pressor effect of intracerebroventricular Ang II in hypertensive rats.
- BUT high intravenous (outside of brain) dose of EC33 did not change BP in hypertensive rats.
= Suggests that Ang II converted to AngIII in the brain
- Intracerebroventricular infusion of APA significantly increases BP.
- Intracerebroventricular infusion of APN (converts Ang III into Ang IIII) in hypertensive rats decreases BP
Drug that inhibits APA + clinical trial information of the drug
= Pro-drug RB150,
Crosses the intestinal, hepatic, and blood-brain barriers
–> cleaved into 2x EC33 molecules (inhibits APA - conversion of Ang II into Ang III)
Reduces BP
- Phase II showed higher the basal daytime ambulatory SBP, the greater the firibastat-induced BP-lowering effect – in people that had higher blood pressure, there was a greater reduction in BP
- Agrees with experimental models of hypertension where firibastat(RB150) acted as an antihypertensive agent and not as a hypotensive agent (didn’t reduce BP but prevented it from increasing)
Is the brain RAS involved in hypertension + give examples of RAAS modulators
- Growing evidence confirms involvement of brain RAS in development of hypertension. Targeting this system with novel agents, such as APA inhibitor prodrug RB150/firibastat, has shown to be effective.
- (Neuroagents) Oral NI956/QGC006 treatment in hypertensive DOCA-salt rats
1. reduced brain APA hyperactivity and
2. BP for 10 hours after a single dose
4. Decreased plasma AVP - At a dose ten times less than RB150.
- NI956/QGC006 has been identified as a best-in-class centrally acting APA inhibitor
What is present on a smooth muscle cell?
Contraction due to influx of Ca through VDCC
State ion channels on smooth muscle cells in vasculature?
CaV1.2; 3.1/3.2
Kv1.2; Kv2; Kv7
KIR (inward rectifying)
KCa (Ca activated k ion channel)
Mixed cation channels
What do Ca and K channels do?
Ca: become more open as membrane potential become less active
K: oppose Ca channels
When + why do VDCC open?
= open more with depolarisation
May be due to :
- Cation (Ca) influx
- or Anion (e.g. GABA-A or glycerine receptor) efflux
Significance of Cl ions in smooth muscle contraction + MOA
SMC ACTIVELY accumulate Chloride ions via:
1. NK2Cl transporter
2. Cl- / HCO3 exchanger
Also found in renal tubules + targets for diuretics
When transporters inhibited -> arteries become less contractile
– vasoconstrictor binds to its receptor -> opens Cl channels -> allows Cl efflux, = depolarisation -> Ca channels open -> Ca infflux
Types of chloride channels
Different Cl ions opened by different mechanisms
Agonist-gated: e.g. Glycine/GABA-A receptors
Voltage-gated: opened by depolarisation (found in skeletal muscles)
Calcium-gated: opened by a rise in intracellular calcium
Mechano-sensitive: opened by membrane stretch
Cyclic nucleotide gated: opened by direct binding of cyclic AMP